Cargando…
Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization
BACKGROUND: Overexpression or mutation of the epidermal growth factor receptor (EGFR) potently enhances the growth of many solid tumors. Tumor cells frequently display resistance to mechanistically-distinct EGFR-directed therapeutic agents, making it valuable to develop therapeutics that work by add...
Autores principales: | Ramirez, Ursula D., Nikonova, Anna S., Liu, Hanqing, Pecherskaya, Anna, Lawrence, Sarah H., Serebriiskii, Ilya G., Zhou, Yan, Robinson, Matthew K., Einarson, Margret B., Golemis, Erica A., Jaffe, Eileen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451962/ https://www.ncbi.nlm.nih.gov/pubmed/26016476 http://dx.doi.org/10.1186/s12885-015-1415-6 |
Ejemplares similares
-
Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin
por: Gaponova, Anna V., et al.
Publicado: (2016) -
Microscopy-Based Automated Live Cell Screening for Small Molecules That Affect Ciliation
por: Zhang, Peishan, et al.
Publicado: (2019) -
Human factors and pathways essential for mediating epigenetic gene silencing
por: Poleshko, Andrey, et al.
Publicado: (2014) -
Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer
por: Deneka, Alexander Y., et al.
Publicado: (2020) -
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
por: Makhov, Petr, et al.
Publicado: (2021)